EYPT
Eyepoint Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.13B
P/E Ratio
—
EPS
$-3.17
Beta
1.91
52W High
$19.11
52W Low
$5.30
50-Day MA
$14.60
200-Day MA
$13.71
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
6.16
PEG Ratio
—
About Eyepoint Pharmaceuticals Inc
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | $31.37M |
| Gross Profit (TTM) | $-187.74M |
| EBITDA | $-241.12M |
| Operating Margin | -450.70% |
| Return on Equity | -72.20% |
| Return on Assets | -38.90% |
| Revenue/Share (TTM) | $0.43 |
| Book Value | $0.40 |
| Price-to-Book | 3.71 |
| Price-to-Sales (TTM) | 35.98 |
| EV/Revenue | 27.07 |
| EV/EBITDA | 11.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 161.70% |
| Shares Outstanding | $83.80M |
| Float | $65.60M |
| % Insiders | 2.67% |
| % Institutions | 104.44% |
Historical Volatility
HV 10-Day
40.34%
HV 20-Day
48.37%
HV 30-Day
50.28%
HV 60-Day
68.51%
HV Rank
5.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($37.17 target)
3
Strong Buy10
BuyData last updated: 4/29/2026